Elevated FBXL6 activates both wild-type KRAS and mutant KRASG12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice. - Xiong HJ; Yu HQ; Zhang J; Fang L; Wu D; Lin XT; Xie CM (Military Medical Research, 2023)